Back

Notification report


Full notification file


General information

Notification Number
B/ES/19/05

Member State to which the notification was sent
Spain

Date of acknowledgement from the Member State Competent Authority
16/01/2019

Title of the Project
A Phase I-IIa trial to assess the safety and antitumor activity of autologous CD44v6 CAR T-cells in acute myeloid leukemia and multiple myeloma expressing CD44v6

Proposed period of release:
01/03/2019 to 31/03/2023

Name of the Institute(s) or Company(ies)
MolMed SpA, Via Olgettina 558 20132
Milano (Italy);


3. Is the same GMO release planned elsewhere in the Community?
Yes:
Germany; Italy; Czech Republic;

Has the same GMO been notified elsewhere by the same notifier?
No

GMO characterization

GMO is a:
Other: mammal

Identity of the GMO:
Genus:Homo; Species:H. Sapiens (genetically modified human lymphocytes)

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
HumanHomoSapiens---

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known